| Literature DB >> 35966022 |
Salvador Vargas-Molina1,2, Manuel García-Sillero1, Richard B Kreider3, Enrique Salinas1, Jorge L Petro4, Javier Benítez-Porres2, Diego A Bonilla5,6,7.
Abstract
Background: Creatine monohydrate (CrM) supplementation has been shown to be an effective and safe nutritional supplement to improve performance; however, the impact of CrM supplementation in young basketball players is less clear. This study evaluated the effects of CrM supplementation during a strength and conditioning training (SCT) program on lower-limb strength parameters and performance in under-16 (U16) basketball players.Entities:
Keywords: Resistance training; adolescents; dietary supplements; physical fitness; power
Mesh:
Substances:
Year: 2022 PMID: 35966022 PMCID: PMC9364731 DOI: 10.1080/15502783.2022.2108683
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 4.948
Figure 1.Schematic representation of the study design. ABK, Abalakov test; CMJ, countermovement jump; CrM, creatine monohydrate; DJ, drop jump; F&R, familiarization and randomization; PPG, points per game; MPG, minutes per game; RT, resistance training; SJ, squat jump.
Figure 2.Organization of the strength training protocol.
Figure 3.CONSORT flow diagram.
Characteristics of study participants.
| CrM | CON | ||
|---|---|---|---|
| Age (years) | 14.3 ± 0.5 | 14.4 ± 0.5 | 0.573 |
| Height (cm) | 174.9 ± 8.3 | 180.5 ± 9.3 | 0.141 |
| BM (kg) | 62.1 ± 7.3 | 70.3 ± 14.5 | 0.097 |
| BMI (kg m2) | 20.3 ± 1.7 | 21.4 ± 2.7 | 0.269 |
Body mass (BM), Body mass index (BMI), Creatine monohydrate group (CrM), Control group (CON). Data are means ± standard deviations.
Results of lower limb power-related variables.
| Group | Before | After | ∆ | P-value | ES | Time | Group | Time x Group | |
|---|---|---|---|---|---|---|---|---|---|
| SJ (cm) | CrM | 28.8 ± 5.3 | 33.3 ± 4.9 | 4.5 ± 3.0 (2.6, 6.4) | <0.01 | 0.9 | <0.01 (0.727) | 0.121 (0.111) | 0.449 (0.028) |
| CON | 32.8 ± 5.3 | 36.5 ± 6.3 | 3.7 ± 2.1 (2.2, 5.1) | <0.01 | 0.6 | ||||
| DJ (cm) | CrM | 1.1 ± 0.3 | 1.6 ± 0.6 | 4.1 ± 2.4 (2.5, 5.6) | <0.01 | 1.0 | <0.01 (0.674) | 0.731 (0.006) | 0.143 (0.099) |
| CON | 1.3 ± 0.3 | 1.6 ± 0.4 | 3.1 ± 1.9 (1.8, 4.4) | 0,001 | 0.9 | ||||
| CMJ (cm) | CrM | 31.1 ± 6.1 | 35.2 ± 6.2 | 0.5 ± 0.4 (0.3, 0.8) | <0.01 | 0.7 | <0.01 (0.742) | 0.495 (0.022) | 0.304 (0.050) |
| CON | 33.6 ± 8.1 | 36.7 ± 6.8 | 0.3 ± 0.2 (0.2, 0.5) | <0.01 | 0.4 | ||||
| ABJ (cm) | CrM | 37.0 ± 7.6 | 41.1 ± 7.0 | 4.1 ± 2.1 (2.8, 5.5) | <0.01 | 0.6 | <0.01 (0.735) | 0.282 (0.055) | 0.003 (0.342) |
| CON | 41.7 ± 8.0 | 43.3 ± 7.3 | 1.6 ± 1.4 (0.7, 2.6) | 0.003 | 0.2 |
The results are expressed as mean ± standard deviation. ES represents Cohen’s effect size from Student´s pairwise comparisons. ηp2 represents squared effect sizes where 0.01 represents a small effect, 0.06 represents medium effect, and 0.14 represents a large effect. Squat jump (SJ), Drop jump (DJ), Counter movement jump (CMJ), Abalakov jump (ABJ), Creatine monohydrate (CrM), Control (CON).
Figure 4.Results of the change (posttest – pretest) of the jump variables of the Creatine (CrM) and Control (Con) Groups. Both groups are plotted on the left axes; the mean difference is plotted on a floating axes on the right as a bootstrap sampling distribution. The mean difference is depicted as a dot; the 95% confidence interval is indicated by the ends of the vertical error bar. SJ, jump squat; CMJ, countermovement jump, DP, drop jump, ABK, Abalakov jump.
Results of points and minutes per game.
| Before | Follow-up | After | Time P (ηp2) | Group P (ηp2) | Time x Group P (ηp2) | |
|---|---|---|---|---|---|---|
| CrM | 6.7 ± 6.2 (2.5, 10.8) | 8.3 ± 7.4 (3.3, 13.2) | 8.2 ± 4.9 (4.9, 11.4) | 0.985 (0.001) | 0.192 (0.088) | 0.049 (0.149) |
| CON | 6.3 ± 3.0 (4.1, 8.4) | 4.2 ± 2.3 (2.6, 5.7) | 4.4 ± 2.1 (3.0, 5.8) | |||
| CrM | 18.1 ± 4.5 (15.0, 21.1) | 19.0 ± 8.4 (13.3, 24.6) | 19.2 ± 7.7 (14.0, 24.3) | 0.613 (0.021) | 0.515 (0.023) | 0.166 (0.094) |
| CON | 18.0 ± 5.5 (14.1, 22.0) | 16.7 ± 5.1 (13.2, 20.1) | 15.5 ± 4.2 (12.7, 18.3) | |||
Data shown as mean ± SD (95% confidence interval). The points and game times are the average of the record of 6 games of each phase before, during, and after the intervention (18 games in total for each group). ηp2 represents squared effect sizes where 0.01 represents a small effect, 0.06 represents medium effect, and 0.14 represents a large effect. Creatine monohydrate group (CrM), Control group (CON).
Figure 5.Points per game (PPG) and minutes per game (MPG) before, during and after the intervention (average of the records in 6 games in each stage). The bar indicates the 95% confidence interval.